CA-88

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameCA-88
Drug Alias NameCA-88
ClassificationSmall moleculesNatural product/Extract
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsRadiation InjuriesDrug-Related Side Effects and Adverse Reactions
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMedigreen Biotechnology Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsRadiation InjuriesDrug-Related Side Effects and Adverse Reactions

Other Information

ATC CodeN/A
Related LinksN/A